二次線溶
WordNet
- not of major importance; "played a secondary role in world events"
- the defensive football players who line up behind the linemen
- being of second rank or importance or value; not direct or immediate; "the stone will be hauled to a secondary crusher"; "a secondary source"; "a secondary issue"; "secondary streams"
- belonging to a lower class or rank
- depending on or incidental to what is original or primary; "a secondary infection"
- a normal ongoing process that dissolves fibrin and results in the removal of small blood clots; "drugs causing fibrinolysis have been utilized therapeutically"
PrepTutorEJDIC
- 『第2の』,2番目の;(…の)次の《+『to』+『名』》 / 派生的な,二次的な,あまり重要でない / 中等学校[教育]の / 二次電流の
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- The Pathophysiology and Management of Acute Traumatic Coagulopathy.
- Duan K1, Yu W1, Li N2.
- Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.Clin Appl Thromb Hemost.2015 Oct;21(7):645-52. doi: 10.1177/1076029613516190. Epub 2013 Dec 19.
- Acute traumatic coagulopathy (ATC) is commonly seen among patients with severe injury and will lead to uncontrolled bleeding diathesis, which is an important contributor to trauma death. During the past 10 years, the understanding of the mechanism causing ATC has changed rapidly. The mechanisms for
- PMID 24363215
- Polymorphisms on PAI-1 and ACE genes in association with fibrinolytic bleeding after on-pump cardiac surgery.
- Ozolina A1,2, Strike E3,4, Nikitina-Zake L5, Jaunalksne I6, Krumina A7, Lacis R8,9, Bjertnaes LJ10, Vanags I11.
- BMC anesthesiology.BMC Anesthesiol.2015 Sep 4;15(1):122.
- BACKGROUND: Carriers of plasminogen activator inhibitor -1 (PAI-1) -675 genotype 5G/5G may be associated with lower preoperative PAI-1 plasma levels and higher blood loss after heart surgery using cardiopulmonary bypass (CPB). We speculate if polymorphisms of PAI-1 -844 A/G and angiotensin convertin
- PMID 26340801
- Coagulation factor VIII, IX and XI levels in north Indian patients with venous thromboembolism: first study from India.
- Chougule A1, Rajpal S, Ahluwalia J, Bose SK, Masih J, Das R, Kumar N, Malhotra P, Suri V.
- Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.Blood Coagul Fibrinolysis.2015 Sep 1. [Epub ahead of print]
- Studies have shown elevated levels of certain coagulation factors as risk factors for venous thromboembolism (VTE). In this study, we investigated the levels of coagulation factor VIII (FVIII), FIX and FXI in north Indian patients with VTE. A total of 123 patients with VTE were screened prospectivel
- PMID 26340461
Japanese Journal
- 小川 孔幸
- 臨床血液 61(7), 799-808, 2020
- <p>凝固第XIII/13因子(FXIII)は,タンパク質を架橋結合させる酵素であるトランスグルタミナーゼの一種で,止血と創傷治癒に寄与する。FXIIIは,酵素活性を有するAサブユニット(FXIII-A)とそれを安定化するBサブユニット(FXIII-B)からなる異種四量体を形成する。自己免疫性後天性凝固第XIII/13因子欠乏症(AiF13D)は,抗FXIII自己抗体によりFXIII活 …
- NAID 130007884760
- Profiles of Coagulation and Fibrinolysis Activation-Associated Molecular Markers of Atypical Hemolytic Uremic Syndrome in the Acute Phase
- Sakurai Satoko,Nangaku Masaomi,Kato Hideki,Yoshida Yoko,Sugawara Yuka,Fujisawa Madoka,Yasumoto Atsushi,Matsumoto Masanori,Fujimura Yoshihiro,Yatomi Yutaka
- Journal of Atherosclerosis and Thrombosis 27(4), 353-362, 2020
- … This study aimed to reveal coagulation and fibrinolysis profiles in aHUS and secondary TMA patients. … </b></p><p><b>Methods: </b>The acute phase samples were available in 15 aHUS and 20 secondary TMA patients. … We examined and compared these tests among aHUS, secondary TMA patients, and healthy volunteer (HV), and evaluated whether patients with aHUS and secondary TMA met DIC criteria.</p><p><b> …
- NAID 130007824992
- 大量出血と止血凝固検査─フィブリノゲン補充療法とトロンボエラストメトリー(ROTEM<SUP>®</SUP>)の重要性とその意義─
- 木倉 睦人,川島 信吾,鈴木 祐二,佐藤 恒久
- 日本臨床麻酔学会誌 34(4), 539-548, 2014
- フィブリノゲンから生成されたフィブリン重合による強い血餅は二次止血の要であり,抗プラスミン剤の有効性は血餅を線溶現象から守る重要性を示唆している.大量出血時のフィブリノゲン補充療法が注目され,フィブリノゲンの目標値が上昇している背景にはフィブリン重合を測定するトロンボエラストメトリー(ROTEM<SUP>®</SUP>)の開発と普及がある.人 …
- NAID 130004687484
Related Links
- fibrinolysis /fi·bri·nol·y·sis/ (fi″brin-ol´ĭ-sis) dissolution of fibrin by enzymatic action.fibrinolyt´ic fi·bri·nol·y·sis (fī′brə-nŏl′ĭ-sĭs) ... Levels can be elevated in cases of intravascular activation of the coagulation system with secondary ...
- fi·bri·nol·y·sis (fī′brə-nŏl′ĭ-sĭs) n. pl. fi·bri·nol·y·ses (-sēz′) The breakdown of fibrin, usually by the enzymatic action of plasmin. fi′bri·no·lyt′ic (-nə-lĭt′ĭk) adj. fibrinolysis (ˌfɪbrɪˈnɒlɪsɪs) n 1. (Physiology) the breakdown of fibrin in blood clots ...
★リンクテーブル★
[★]
- 英
- secondary fibrinolysis
- 同
- 二次線維素溶解
- 関
- 一次線溶
[★]
- (地位・価値・重要性などが)第2の、2番目の、(~の)次の(to)。二次的な、従位の
- Postmortem examination of patients with such obstructions without a history of clinical manifestations of myocardial ischemia often shows macroscopic scars secondary to MI in regions supplied by diseased coronary arteries, with or without collateral circulation.
- in the past the commonest cause of death has been venous thrombosis followed by infection secondary to severe neutropenia and hemorrhage secondary to severe thrombocytopenia.(HIM.661)(重度の好中球減少に次ぐ感染と血小板減少に次ぐ出血に続発する静脈血栓症が昔の最も一般的な死因であった)